Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of the world’s leading labs. Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses. Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.

SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA.

Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD.

Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA.

The Kobayashi Pharmaceutical Group provides a variety of products in fields such as pharmaceuticals, fragrances, dietary supplements and daily necessities. Providing products in these diverse fields is a business activity based on the broader management philosophy of “Providing Great Pleasure to People and Society” regardless of the current business domain. The current management philosophy was newly created in April 1999 by adding the meanings of “creation and innovation” and “Something New Something Different”, which are one of the characteristics of the Kobayashi Pharmaceutical Group, to the conventional management philosophy. is. The Kobayashi Pharmaceutical Group believes that pursuing the provision of “Pleasure” for people and society in this management philosophy is the significance of the Kobayashi Pharmaceutical Group.

QuantaMatrix, Inc. provides optical devices for microbiological and molecular diagnostics. Its products include QMAC and QMAP. The company was founded by Sung-Hoon Kwon on November 29, 2010 and is headquartered in Seoul, South Korea.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Kanto Chemical Co. Inc. develops and manufactures products in the area of reagents chemicals. It offers ultra pure & special functional chemicals and Chemical Dispense System (CDS). The firm provides products for the diagnostics and electronics industry. The company was founded on November 13, 1944 and is headquartered in Tokyo, Japan.

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Tokyo Metropolitan Institute of Medical Science is a Japanese private company. The firm operates as a research institute that develops medicine.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Avigen, Inc., a biopharmaceutical company, engages in identifying and developing products to treat patients with neurological and other disorders. The company develops the AV411 portfolio, which includes the phase II-stage lead drug compound and proprietary analogs and represents novel, non-opioid drugs for the treatment of various large pain and drug addiction indications. AV411 is an orally bioavailable small molecule; a glial attenuator that suppresses pro-inflammatory cytokines IL-1 beta, TNF alpha, and IL-6; and a toll-like receptor 4 (TLR4) functional antagonist that may contribute to its attenuation of neuroinflammation. AV411 is being evaluated in Phase Ib/IIa clinical trials. The company was founded in 1992 and is headquartered in Alameda, California. As of December 18, 2009, Avigen, Inc. operates as a subsidiary of MediciNova Inc

Affinity Biosensors develops and manufactures analytical instruments for research, manufacturing, and life sciences. Its technology, LifeScale, is the current system to exploit Resonant Mass Measurement technology leading to new, unique, and rapid techniques for the measurement and observation of microbe growth and response. The company was founded in 2006 and is based in Santa Barbara, California.

Hunan Tianqi Medical Technology Co., Ltd., established on 2000-09-27, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Drug internet information service;Internet Information Service for Medical Devices;Class III Medical Device Leasing;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;daily mask(non-medical)Production;daily mask(non-medical)Sales;Computer System Services;software development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of plastic products;Sales of plastic products;glassware manufacturing;Glassware Sales;Manufacturing of experimental analysis instruments;Experimental analysis instrument sales;Manufacture of new membrane materials;Sales of new membrane materials;Class I Medical Device Leasing;Class II Medical Device Leasing;Import and export;Technology Import and Export;Import and export agency(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Nanjing Rongkangbo Biotechnology Co., Ltd., established on 2016-04-08, Business scope includes biotechnology(Do not engage in human stem cells,Development and application of genetic diagnosis and treatment technology),medical instruments,Medical technology research and development,technology transfer,Technical Services,technical consulting;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);Enterprise Management Services;Corporate Image Planning,Exhibition display service,account Serive,Etiquette service;Business Consulting;marketing planning;Health Information Consultation,Health Management Consulting(Neither of the above two items shall be engaged in medical treatment activities,psychological counseling);Class I medical device,cosmetic,General merchandise sales;Medical Testing Services;Industrial Design Services;Professional design service;Technology promotion service and application of optical components,microscope,Research on optoelectronic integrated products and optical processing equipment,manufacturing and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Jiangsu Zhongxin Pharmaceutical Co., Ltd., established on 2011-03-30, Business scope includes research and development of pharmaceutical products,Production,technology transfer,technical consulting,Technical Services;medical instruments(Ikind,IIkind,IIIkind)and in vitro diagnostic reagents(Ikind,IIkind,IIIkind)research and development,Production;Healthy food,Production of health care products;Sales of self-produced products;Healthy food,Health Supplies,retail of cosmetics,wholesale,Import and export and commission agency(except auction).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Japanese Cancer Research Foundation supports the establishment of a cancer institute and its affiliated hospital. It has been leading the research and treatment of cancer thru activities integrating basic and clinical research. It shows their accomplishments in cancer research and treatment over a long history. It is one of the the world-s institutes in bioscience. They are making accomplishments in the treatment of cancer its related diseases with efficient medical staff and leading-edge medical equipment.